Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Evolent Health's ebitda for the twelve months ending Sep 30, 2026 was -$324.93M, down 508.2% year over year. For fiscal 2025 it was -$294.29M, down 477.8% from the year before. The highest annual figure on record is $77.89M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$294.29M | -477.8% |
| FY2024 | Dec 31, 2024 | $77.89M | +49.2% |
| FY2023 | Dec 31, 2023 | $52.20M | -26.3% |
| FY2022 | Dec 31, 2022 | $70.84M | +301.9% |
| FY2021 | Dec 31, 2021 | $17.63M | – |
| FY2020 | Dec 31, 2020 | -$201.37M | – |
| FY2019 | Dec 31, 2019 | -$247.97M | – |
| FY2018 | Dec 31, 2018 | -$2.97M | – |
| FY2017 | Dec 31, 2017 | -$40.47M | – |
| FY2016 | Dec 31, 2016 | -$220.20M | – |
| FY2015 | Dec 31, 2015 | -$35.81M | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | -$19.95M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.31M | -37.5% |
| Q2 FY2026 | Jun 30, 2026 | $12.01M | -45.4% |
| Q1 FY2026 | Mar 31, 2026 | $10.96M | -51.2% |
| Q4 FY2025 | Dec 31, 2025 | -$363.19M | -3494.3% |
| Q3 FY2025 | Sep 30, 2025 | $24.50M | +82.4% |
| Q2 FY2025 | Jun 30, 2025 | $21.97M | -41.7% |
| Q1 FY2025 | Mar 31, 2025 | $22.44M | +39.4% |
| Q4 FY2024 | Dec 31, 2024 | $10.70M | +29.7% |
| Q3 FY2024 | Sep 30, 2024 | $13.43M | -7.1% |
| Q2 FY2024 | Jun 30, 2024 | $37.66M | +256.4% |
| Q1 FY2024 | Mar 31, 2024 | $16.09M | -14.9% |
| Q4 FY2023 | Dec 31, 2023 | $8.25M | -53.9% |
| Q3 FY2023 | Sep 30, 2023 | $14.47M | -52.0% |
| Q2 FY2023 | Jun 30, 2023 | $10.57M | +0.8% |
| Q1 FY2023 | Mar 31, 2023 | $18.92M | +53.7% |
| Q4 FY2022 | Dec 31, 2022 | $17.90M | +562.8% |
| Q3 FY2022 | Sep 30, 2022 | $30.15M | +264.2% |
| Q2 FY2022 | Jun 30, 2022 | $10.48M | +44.6% |
| Q1 FY2022 | Mar 31, 2022 | $12.31M | – |
| Q4 FY2021 | Dec 31, 2021 | $2.70M | -86.1% |
| Q3 FY2021 | Sep 30, 2021 | $8.28M | – |
| Q2 FY2021 | Jun 30, 2021 | $7.25M | – |
| Q1 FY2021 | Mar 31, 2021 | -$598.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $19.39M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$210.21M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.95M | – |
| Q4 FY2019 | Dec 31, 2019 | -$200.92M | -15784.7% |
| Q3 FY2019 | Sep 30, 2019 | -$4.73M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.94M | -1030.8% |
| Q1 FY2019 | Mar 31, 2019 | -$32.38M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.28M | – |
| Q3 FY2018 | Sep 30, 2018 | -$678.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $1.07M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.64M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.12M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.30M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.21M | – |
| Q1 FY2017 | Mar 31, 2017 | -$14.84M | – |
| Q4 FY2016 | Dec 31, 2016 | -$27.38M | – |
See a number that looks wrong?